$1.13
arrow_drop_down1.73%Key Stats | |
---|---|
Open | $1.14 |
Prev. Close | $1.15 |
EPS | -1.21 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $5.06M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 1.09 | 1.25 |
52 Week Range | 0.84 | 4.50 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.21 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Silo Pharma secures $2.1 million in direct offering - Investing.com
Gold Down 2%; SLB Posts Upbeat Earnings - Benzinga
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia